Orbitrex Peptides
Finnrick has tested 26 samples from Orbitrex Peptides across 3 products.
orbitrexpeptide.is/Finnrick verified this link on 31 Oct 2025
Vendor-Supplied Policies
Sample Authentication Guidance
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| GHK-Cu | 4 | 25 Oct 2025 | 2 Jun 2026 | |||||
| Tirzepatide | 4 | 23 Nov 2025 | 29 Mar 2026 | |||||
| Retatrutide | 15 | 7 Oct 2025 | 28 May 2026 | |||||
Some samples were submitted by Orbitrex Peptides as part of the Launch with Finnrick vendor support program. Samples are otherwise either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
Based on 12 overall satisfaction reports
People who submitted test requests to Finnrick gave Orbitrex Peptides an average satisfaction rating of 5.0 out of 5 across 12 reports associated with samples received and tested by Finnrick.
Most recent Orbitrex Peptides tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 2 Jun 2026 | GHK-Cu | View | 50mg | 47.2mg | 49.9mg | +5.7% | 99.90% | n/a | GHK50526US | Green & Blue label / Green crimp / Blue cap | Lab E | Public | |
| 28 May 2026 | Retatrutide | View | 10mg | (no batch claim) | 10.3mg | +3.0% | 99.90% | below LOQ | (no batch ID) | Black label / Black crimp / Blue cap | Lab E | Public | |
| 28 Apr 2026 | Retatrutide | View | 10mg | 11.3mg | 9.74mg | -13.7% | 99.90% | n/a | 3G101125 | Black Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 28 Apr 2026 | Retatrutide | View | 36mg | 49.0mg | 36.9mg | -24.7% | 99.90% | n/a | 3G361125 | Black Label / Gold Crimp / Clear Cap | Lab E | Public | |
| 23 Apr 2026 | GHK-Cu | View | 50mg | 50.4mg | 56.5mg | +12.2% | 99.90% | below LOQ | GHK50326 | Black Label / Silver Crimp / White Cap | Lab E | Public | |
| 23 Apr 2026 | Retatrutide | View | 10mg | (no batch claim) | 9.88mg | -1.2% | 99.90% | low | 3G101125 | Black Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 29 Mar 2026 | Tirzepatide | View | 10mg | 11.4mg | 11.6mg | +2.1% | 99.80% | n/a | 2G101125 | Yellow Label / Silver Crimp / Yellow Cap | Lab G | Public | |
Corrections
- 9 Mar 2026: Retatrutide
- Sample p4bqre8: original COA reported purity of 97.83%. Upon vendor objection, lab investigated and found the automated integration routine picked up noise as peaks and erroneously integrated it. Manual revision led to updated calculations for purity and quantity. The lab issued an updated COA. This sample's test score changed from 3.7 to 7.0, and the Finnrick Rating for Orbitrex Retatrutide changed from D to A.
- 9 Mar 2026: Tirzepatide
- Sample nwwrwhu: original COA reported purity of 92.83%. Upon vendor objection, lab investigated and found the automated integration routine picked up noise as peaks and erroneously integrated it. Manual revision led to updated calculations for purity and quantity. The lab issued an updated COA. This sample's test score changed from 5.9 to 9.0, and the Finnrick Rating for Orbitrex Tirzepatide changed from B to A.
About Orbitrex Peptides Test Results From Finnrick
Orbitrex Peptides is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 3 products and 26 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud) and customer satisfaction reports with sub-scores that provide additional context. Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
Orbitrex Peptides Testing Activity & Score Summary
In the past 30 days, Finnrick has published 2 new test results for Orbitrex Peptides, and 9 in the past three months. The overall dataset includes 26 tested samples with an average score of 8.5/10 across all products.
Across 23 identity-tested samples, 100% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.9%. Approximately 100% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products (top 3):
- Retatrutide (15 tests, 100% identity pass, median purity 99.9%) — Test scores are highly variable, ranging from 5.9 to 10.0 (average 8.4/10), suggesting significant batch-to-batch differences.
- Tirzepatide (4 tests, 100% identity pass, median purity 99.6%) — Scores are tightly clustered between 8.2 and 9.2, indicating consistent quality across batches.
- GHK-Cu (4 tests, 100% identity pass, median purity 99.9%) — Test scores are highly variable, ranging from 7.0 to 9.2 (average 8.5/10), suggesting significant batch-to-batch differences.